Protocolo de Montreal relativo a las sustancias que agotan la capa de ozono
Anexo C: Sustancias controladas
| Grupo |
Sustancia |
Número de isómeros |
Potencial de agotamiento del ozono* |
| Grupo I |
|
|
|
| CHFCl2 |
(HCFC21)** |
1 |
0.04 |
| CHF2Cl |
(HCFC22)** |
1 |
0.055 |
| CH2FCl |
(HCFC31) |
1 |
0.02 |
| C2HFCl4 |
(HCFC121) |
2 |
0.01–0.04 |
| C2HF2Cl3 |
(HCFC122) |
3 |
0.02–0.08 |
| C2HF3Cl2 |
(HCFC123) |
3 |
0.02–0.06 |
| CHCl2CF3 |
(HCFC123)** |
– |
0.02 |
| C2HF4Cl |
(HCFC124) |
2 |
0.02–0.04 |
| CHFClCF3 |
(HCFC124)** |
– |
0.022 |
| C2H2FCl3 |
(HCFC131) |
3 |
0.007–0.05 |
| C2H2F2Cl2 |
(HCFC132) |
4 |
0.008–0.05 |
| C2H2F3Cl |
(HCFC133) |
3 |
0.02–0.06 |
| C2H3FCl2 |
(HCFC141) |
3 |
0.005–0.07 |
| CH3CFCl2 |
(HCFC141b)** |
– |
0.11 |
| C2H3F2Cl |
(HCFC142) |
3 |
0.008–0.07 |
| CH3CF2Cl |
(HCFC142b)** |
– |
0.065 |
| C2H4FCl |
(HCFC151) |
2 |
0.003–0.005 |
| C3HFCl6 |
(HCFC221) |
5 |
0.015–0.07 |
| C3HF2Cl5 |
(HCFC222) |
9 |
0.01–0.09 |
| C3HF3Cl4 |
(HCFC223) |
12 |
0.01–0.08 |
| C3HF4Cl3 |
(HCFC224) |
12 |
0.01–0.09 |
| C3HF5Cl2 |
(HCFC225) |
9 |
0.02–0.07 |
| CF3CF2CHCl2 |
(HCFC225ca)** |
– |
0.025 |
| CF2ClCF2CHClF |
(HCFC225cb)** |
– |
0.033 |
| C3HF6Cl |
(HCFC226) |
5 |
0.02–0.10 |
| C3H2FCl5 |
(HCFC231) |
9 |
0.05–0.09 |
| C3H2F2Cl4 |
(HCFC232) |
16 |
0.008–0.10 |
| C3H2F3Cl3 |
(HCFC233) |
18 |
0.007–0.23 |
| C3H2F4Cl2 |
(HCFC234) |
16 |
0.01–0.28 |
| C3H2F5Cl |
(HCFC235) |
9 |
0.03–0.52 |
| C3H3FCl4 |
(HCFC241) |
12 |
0.004–0.09 |
| C3H3F2Cl3 |
(HCFC242) |
18 |
0.005–0.13 |
| C3H3F3Cl2 |
(HCFC243) |
18 |
0.007–0.12 |
| C3H3F4Cl |
(HCFC244) |
12 |
0.009–0.14 |
| C3H4FCl3 |
(HCFC251) |
12 |
0.001–0.01 |
| C3H4F2Cl2 |
(HCFC252) |
16 |
0.005–0.04 |
| C3H4F3Cl |
(HCFC253) |
12 |
0.003–0.03 |
| C3H5FCl2 |
(HCFC261) |
9 |
0.002–0.02 |
| C3H5F2Cl |
(HCFC262) |
9 |
0.002–0.02 |
| C3H6FCl |
(HCFC271) |
5 |
0.001–0.03 |
| Grupo II |
|
|
|
| CHFBr2 |
|
1 |
1.00 |
| CHF2Br |
(HBFC22B1) |
1 |
0.74 |
| CH2FBr |
|
1 |
0.73 |
| C2HFBr4 |
|
2 |
0.3–0.8 |
| C2HF2Br3 |
|
3 |
0.5–1.8 |
| C2HF3Br2 |
|
3 |
0.4–1.6 |
| C2HF4Br |
|
2 |
0.7–1.2 |
| C2H2FBr3 |
|
3 |
0.1–1.1 |
| C2H2F2Br2 |
|
4 |
0.2–1.5 |
| C2H2F3Br |
|
3 |
0.7–1.6 |
| C2H3FBr2 |
|
3 |
0.1–1.7 |
| C2H3F2Br |
|
3 |
0.2–1.1 |
| C2H4FBr |
|
2 |
0.07–0.1 |
| C3HFBr6 |
|
5 |
0.3–1.5 |
| C3HF2Br5 |
|
9 |
0.2–1.9 |
| C3HF3Br4 |
|
12 |
0.3–1.8 |
| C3HF4Br3 |
|
12 |
0.5–2.2 |
| C3HF5Br2 |
|
9 |
0.9–2.0 |
| C3HF6Br |
|
5 |
0.7–3.3 |
| C3H2FBr5 |
|
9 |
0.1–1.9 |
| C3H2F2Br4 |
|
16 |
0.2–2.1 |
| C3H2F3Br3 |
|
18 |
0.2–5.6 |
| C3H2F4Br2 |
|
16 |
0.3–7.5 |
| C3H2F5Br |
|
8 |
0.9–14.0 |
| C3H3FBr4 |
|
12 |
0.08–1.9 |
| C3H3F2Br3 |
|
18 |
0.1–3.1 |
| C3H3F3Br2 |
|
18 |
0.1–2.5 |
| C3H3F4Br |
|
12 |
0.3–4.4 |
| C3H4FBr3 |
|
12 |
0.03–0.3 |
| C3H4F2Br2 |
|
16 |
0.1–1.0 |
| C3H4F3Br |
|
12 |
0.07–0.8 |
| C3H5FBr2 |
|
9 |
0.04–0.4 |
| C3H5F2Br |
|
9 |
0.07–0.8 |
| C3H6FBr |
|
5 |
0.02–0.7 |
| |
|
|
|
| Grupo III |
|
|
|
| CH2BrCl |
Bromoclorometano |
1 |
0.12 |
* Cuando se indica una gama de PAO, a los efectos del Protocolo se utilizará el valor más alto de dicha gama. Los PAO enumerados como un valor único se determinaron a partir de cálculos basados en mediciones de laboratorio. Los enumerados como una gama se basan en estimaciones y, por consiguiente, tienen un grado mucho mayor de incertidumbre: un factor de dos para los HCFCs. La gama comprende un grupo isomérico. El valor superior es la estimación del PAO del isómero con el PAO más elevado, y el valor inferior es la estimación del PAO del isómero con el PAO más bajo.
** Identifica las sustancias más viables comercialmente. Los valores de PAO que las acompañan se utilizarán a los efectos del Protocolo.
|
